Considering the aging baby boomer population, spending trends can only rise from current levels. In particular, Medicare spending will experience a surge as more boomers enroll. Moreover, spending on physician and clinical services, pharmaceuticals and medical devices keeps rising. This medical device maker has a revolutionary product for the heart health diagnostic market. iRhythm Technologies (NASDAQ:IRTC) offers a cardiac monitoring solution, Zio XT, for heart rhythm monitoring, enabling the detection of ...

GE HealthCare Technologies (GEHC) recently announced that it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for a total consideration of approximately $51 million. With integrated AI-driven picture analysis tools, Intelligent Ultrasound is a leader in making ultrasound more intelligent and effective. With the acquisition of the business, GE HealthCare intends to integrate the technology solutions th ...

As part of HDR brachytherapy, radioactive sources are implanted by needles into the prostate gland to treat prostate cancer. Clinicians typically design these operations using ultrasound or computed tomography (CT) imaging. Critical structural toxicity can be decreased by using MRI in the planning of brachytherapy treatments. MIM Symphony HDR Prostate stands out in the market by correcting MRI orientation and offering MRI guidance during HDR prostate procedures. In April 2024, GE Healthcare announced the cl ...

GE Healthcare Technologies, Inc. (GEHC) , in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children's, has announced a cutting-edge initiative to accelerate MRI innovation. This collaboration will provide a well-established MRI Research and Development (R&D) center of excellence on UC's medical campus, enabling direct interaction between clinical investigators and GE HealthCare scientists. The initiative is supported by an R&D grant from JobsOhio, aimed at boosting engineer ...

Cincinnati, Ohio, June 26, 2024 (GLOBE NEWSWIRE) -- Ohio-Based MRI Research Center and Job Creation Announced by GE HealthCare, University of Cincinnati, UC Health, Cincinnati Children's, JobsOhio, and REDI Cincinnati CINCINNATI, OHIO — June 26 — GE HealthCare (NASDAQ:GEHC), University of Cincinnati (UC), UC Health, and Cincinnati Children's are establishing a new collaboration with the goal to accelerate MRI innovation. The collaboration intends to create a co-located MRI Research and Development (R&D) cen ...

Core Insights - GE HealthCare Technologies Inc. has installed its latest Allia Image Guided System (IGS) Pulse at Heart Hospital of New Mexico, marking the first installation in the U.S. This system aims to enhance image quality and workflow for diagnosing and treating cardiovascular diseases (CVDs) [1][12]. Company Developments - The installation of the Allia IGS Pulse system is expected to strengthen GE HealthCare's position in the CVD treatment market, which is significant given that heart disease has been the leading cause of death in the U.S. for decades, affecting nearly 48.6% of individuals over 20 years old [2][12]. - HHNM, as New Mexico's only hospital dedicated to heart care, anticipates providing innovative treatment options and keeping patients close to home [3]. - GE HealthCare has also entered an agreement with Salud Digna to deploy digital solutions aimed at improving care efficiency across various imaging systems in Mexico [5]. Market Insights - The global electrophysiology market, relevant to GE HealthCare's offerings, was valued at $8.2 billion in 2023 and is projected to reach $15.1 billion by 2028, growing at a CAGR of 13% due to the rising prevalence of CVDs and technological advancements [4]. - The collaboration with HHNM is expected to address healthcare challenges and enhance patient and provider experiences [12]. Performance Metrics - GE HealthCare's shares have increased by 1.6% over the past year, contrasting with a 26.4% decline in the industry, while the S&P 500 has grown by 26.1% during the same period [16].

OmnifyXR is currently available exclusively with GE HealthCare interventional X-ray systems, such as the Allia IGS platform and Innova IGS platform with AutoRight, that utilize digital video distribution. The latest announcement is expected to strengthen GE HealthCare's foothold in the global interventional radiology space. Significance of the Announcement Per GE HealthCare, image-guided therapy is a fast-evolving space that leverages advanced imaging and visualization solutions to treat many conditions, in ...

Core Insights - The MedTech industry is increasingly integrating Generative AI (GenAI) to enhance diagnostic precision and optimize treatment strategies, marking a significant shift from traditional methods [1][3][4] Group 1: Industry Overview - The Generative AI market is projected to grow from $40 billion in 2022 to $1.3 trillion by 2032, indicating a substantial expansion in the sector [4] - GenAI is being utilized across various healthcare fields, including drug discovery, clinical trials, and administrative tasks, allowing companies to better meet patient needs and capture market share [5] Group 2: Key Companies - Zimmer Biomet (ZBH) has developed AI-based solutions like WalkAI for personalized outcome predictions and the Omni Suite for optimizing surgical workflows [10][11] - GE HealthCare (GEHC) has been recognized for its AI-enabled medical devices, with 72 FDA clearances, and is enhancing its ultrasound portfolio with AI applications [13][14] - Medtronic (MDT) is integrating AI into its surgical platforms and has introduced innovations like ColonPRO software for improved polyp detection [16][17] Group 3: Financial Performance - ZBH is expected to see a 7.3% year-over-year increase in 2024 earnings, supported by a 4.9% revenue improvement [12] - GEHC anticipates an 8.7% year-over-year increase in 2024 earnings, driven by a 3% revenue growth [15] - MDT is projected to achieve a 4.6% year-over-year growth in fiscal 2025 earnings, with a 3.2% revenue increase [18]

The agreement between GE HealthCare and Salud Digna also includes the deployment of a digital dose management solution to track and manage radiation and contrast exposure within the patient workflow. Per GE HealthCare, the solutions and technologies are aimed at helping improve care for the 20 million patients Salud Digna treats every year. The protocol standardization solution that will be deployed at Salud Digna will likely allow the health system to track and update protocols on CT and MR equipment acros ...

FinkAvenue Earlier this year, I decided to revisit one of the companies that was spun off from the former conglomerate known as General Electric. That happens to be the healthcare side of the firm, known today as GE HealthCare Technologies (NASDAQ:GEHC). From the time I had rated it a 'strong buy' in December of last year through the time that my article was published in March, shares had seen an upside of 35.7%. And since I first rated it a 'strong buy' in early January of 2023, shares had soared by 55.4%. ...